Notice Title

Consent to the Distribution of New Medicines

Publication Date
10 Sep 2015

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2015-go5305

Issue Number

98
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturers:

Exforge HCT
Amlodipine besilate 6.94mg equivalent to Amlodipine 5mg
Hydrochlorothiazide 12.5mg
Valsartan 160mg
Film coated tablet
Novartis New Zealand Limited
Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturers:

Exforge HCT
Amlodipine besilate 6.94mg equivalent to Amlodipine 5mg
Hydrochlorothiazide 25mg
Valsartan 160mg
Film coated tablet
Novartis New Zealand Limited
Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturers:

Exforge HCT
Amlodipine besilate 13.87mg equivalent to Amlodipine 10mg
Hydrochlorothiazide 12.5mg
Valsartan 160mg
Film coated tablet
Novartis New Zealand Limited
Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturers:

Exforge HCT
Amlodipine besilate 13.87mg equivalent to Amlodipine 10mg
Hydrochlorothiazide 25mg
Valsartan 160mg
Film coated tablet
Novartis New Zealand Limited
Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturers:

Exforge HCT
Amlodipine besilate 13.87mg equivalent to Amlodipine 10mg
Hydrochlorothiazide 25mg
Valsartan 320mg
Film coated tablet
Novartis New Zealand Limited
Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Dated this 4th day of September 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).